Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Pecquet

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Combinatorial Chemistry & High Throughput Screening|October 18, 2016
A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative NeoplasmsAnna Ngo, Ann Zhufang Koay, Christian Pecquet, et al.
Blood|November 2, 2022
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosisSara Lecomte, Julien Devreux, Grégoire de Streel, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Blood|December 10, 2009
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptorChristian Pecquet, Judith Staerk, Ronan Chaligné, et al.
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Iscience|May 26, 2020
Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA MethylationSafak Caglayan, Adnan Hashim, Artur Cieslar-Pobuda, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Blood|January 9, 2014
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitorsCaroline Marty, Cécile Saint-Martin, Christian Pecquet, et al.
Blood|December 16, 2015
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutantsIlyas Chachoua, Christian Pecquet, Mira El-Khoury, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Combinatorial Chemistry & High Throughput Screening|October 18, 2016
A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative NeoplasmsAnna Ngo, Ann Zhufang Koay, Christian Pecquet, et al.
Blood|November 2, 2022
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosisSara Lecomte, Julien Devreux, Grégoire de Streel, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Blood|December 10, 2009
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptorChristian Pecquet, Judith Staerk, Ronan Chaligné, et al.
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Iscience|May 26, 2020
Optic Atrophy 1 Controls Human Neuronal Development by Preventing Aberrant Nuclear DNA MethylationSafak Caglayan, Adnan Hashim, Artur Cieslar-Pobuda, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Blood|January 9, 2014
Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitorsCaroline Marty, Cécile Saint-Martin, Christian Pecquet, et al.
Blood|December 16, 2015
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutantsIlyas Chachoua, Christian Pecquet, Mira El-Khoury, et al.
Pageof 4